Perspectives on the future of bisphosphonate use in breast cancer patients

被引：4

作者：

Clemons, M

Rea, D

机构：

[1] Toronto Sunnybrook Reg Canc Ctr, Div Med Oncol, Toronto, ON M4N 3M5, Canada

[2] Univ Birmingham, Inst Canc Studies, Canc Res UK, Birmingham, W Midlands, England

来源：

SEMINARS IN ONCOLOGY | 2004年 / 31卷 / 05期

关键词：

D O I：

10.1053/j.seminoncol.2004.07.029

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：87 / 91

页数：5

共 34 条

[1] Oral ibandronate reduces the risk of skeletal complications in breast cancer patients with metastatic bone disease: results from two randomised, placebo-controlled phase III studies [J].

Body, JJ ;

Diel, IJ ;

Lichinitzer, M ;

Lazarev, A ;

Pecherstorfer, M ;

Bell, R ;

Tripathy, D ;

Bergstronn, B .

BRITISH JOURNAL OF CANCER, 2004, 90 (06) :1133-1137

[2] Intravenous ibandronate reduces the incidence of skeletal complications in patients with breast cancer and bone metastases [J].

Body, JJ ;

Diel, IJ ;

Lichinitser, MR ;

Kreuser, ED ;

Dornoff, W ;

Gorbunova, VA ;

Budde, M ;

Bergström, B .

ANNALS OF ONCOLOGY, 2003, 14 (09) :1399-1405

[3]

Brown JP, 2002, CAN MED ASSOC J, V167, pS1

[4] 'Arimidex' (anastrozole) versus tamoxifen as adjuvant therapy in postmenopausal women with early breast cancer-efficacy overview [J].

Buzdar, AU .

JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 2003, 86 (3-5) :399-403

[5] Should all breast cancer patients with symptomatic bone metastases be treated with bisphosphonates? The case in support [J].

Clemons, M .

CLINICAL ONCOLOGY, 2004, 16 (02) :108-111

[6] Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard? [J].

Clemons, M ;

Coleman, RE ;

Verma, S .

CANCER TREATMENT REVIEWS, 2004, 30 (04) :325-332

[7]

Clemons Mark, 2004, Can J Clin Pharmacol, V11, pe168

[8]

Coleman R, 2004, BONE, V34, pS85

[9] A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer [J].

Coombes, RC ;

Hall, E ;

Gibson, LJ ;

Paridaens, R ;

Jassem, J ;

Delozier, T ;

Jones, SE ;

Alvarez, I ;

Bertelli, G ;

Ortmann, O ;

Coates, AS ;

Bajetta, E ;

Dodwell, D ;

Coleman, RE ;

Fallowfield, LJ ;

Mickiewicz, E ;

Andersen, J ;

Lonning, PE ;

Cocconi, G ;

Stewart, A ;

Stuart, N ;

Snowdon, CF ;

Carpentieri, M ;

Massimini, G ;

Bliss, JM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (11) :1081-1092

[10] Reduction in new metastases in breast cancer with adjuvant clodronate treatment [J].

Diel, IJ ;

Solomayer, EF ;

Costa, SD ;

Gollan, C ;

Goerner, R ;

Wallwiener, D ;

Kaufmann, M ;

Bastert, G .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 339 (06) :357-363

← 1 2 3 4 →